Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine

Methods Mol Med. 2003:79:55-73. doi: 10.1385/1-59259-358-5:55.

Abstract

The existing data indicate that MDMA produces long-term deficits in markers of 5-HT axon terminals in the rodent brain. Increased cleavage of the cytoskeletal protein tau, impairment of axonal transport, and functional consequences associated with a 5-HT depleting regimen of MDMA support the view that MDMA induces structural brain damage, that is, axonal degeneration. A confluence of oxidative stress and bioenergetic stress induced by MDMA is hypothesized to underlie the process of MDMA neurotoxicity (Fig. 3). The actions of MDMA on the 5-HT transporter to promote free radical formation and/or intracellular calcium may synergize with MDMA-induced disturbances in cellular energetics and hyperthermia to effect selective toxicity to 5-HT axon terminals.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Brain / drug effects
  • Brain / metabolism
  • Brain / physiopathology
  • Calcium / metabolism
  • Dopamine / metabolism
  • Fever
  • Free Radical Scavengers / metabolism
  • N-Methyl-3,4-methylenedioxyamphetamine / pharmacology*
  • N-Methyl-3,4-methylenedioxyamphetamine / toxicity*
  • Presynaptic Terminals / physiology
  • Rats
  • Receptors, Serotonin / metabolism
  • Serotonin / metabolism
  • Serotonin Agents / pharmacology*
  • Serotonin Agents / toxicity*

Substances

  • Free Radical Scavengers
  • Receptors, Serotonin
  • Serotonin Agents
  • Serotonin
  • N-Methyl-3,4-methylenedioxyamphetamine
  • Calcium
  • Dopamine